AssetMark Inc’s Natus Medical Inc NTUS Stock Holding History

AssetMark Inc’s Portfolio NTUS Stock Details NTUS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-11	Closed	–	–	2125
2017 Q4	$0	Buy	+11	New	+$439	﹤0.01%	2203
2017 Q1	–	Sell	-3	Closed	–	–	1491
2016 Q4	$0	Buy	+3	New	+$118	﹤0.01%	1423
2016 Q1	–	Sell	-20	Closed	-$1K	–	1465
2015 Q4	$1K	Buy	20 +16	+400%	+$741	﹤0.01%	1303
2015 Q3	$0	Buy	+4	New	+$170	﹤0.01%	883

Other funds holding NTUS

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

SAM

Silvercrest Asset Management New York $13.8B AUM 28.39% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

CIM

Confluence Investment Management St. Louis, Missouri $6.4B AUM 9.79% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

IAM

Impax Asset Management Portsmouth, New Hampshire $1.69B AUM 16.26% 1-Year Est. Return

VCM

Voce Capital Management San Francisco, California $57.8M AUM 9.28% 1-Year Est. Return

AssetMark Inc's NTUS Position: Q1 2018 in Review

AssetMark Inc sold out of Natus Medical Inc (NTUS) in Q1 2018, closing a stake of 11 shares.

AssetMark Inc first reported a position in NTUS in Q3 2015 and held it in 4 quarters. The position peaked at $1K in Q4 2015. 184 funds tracked by Wall St. Rank hold NTUS as of Q1 2018.

AssetMark Inc reported no remaining Natus Medical Inc position as of Q1 2018 after selling out during the quarter.
AssetMark Inc sold 11 Natus Medical Inc shares in Q1 2018.
AssetMark Inc first reported a position in Natus Medical Inc in Q3 2015 and held it in 4 quarters.
AssetMark Inc's Natus Medical Inc position peaked at $1K in Q4 2015.
184 funds tracked by Wall St. Rank held Natus Medical Inc as of Q1 2018.

Based on AssetMark Inc's 13F filing for Q1 2018, filed 16 May 2018.